Savannah, GANCT07117487Now EnrollingIRB Ready

Respiratory Syncytial Virus Clinical Trial in Savannah, GA

Access cutting-edge respiratory syncytial virus treatment through this clinical trial at a research site in Savannah. Study-provided care at no cost to qualified participants.

Sponsored by ModernaTX, Inc.

Quick Self-Assessment

See if you qualify for this Savannah location

Preparing your pre-screening questions...

Expert Care in Savannah

Access respiratory syncytial virus specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related respiratory syncytial virus treatment provided free

Apply for This Savannah Location

Check if you qualify for this respiratory syncytial virus clinical trial in Savannah, GA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Savannah

    Convenient for GA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Savannah site if eligible
  4. 4Begin participation

About This Respiratory Syncytial Virus Study in Savannah

The purpose of this study is to evaluate safety, tolerability and immunogenicity of mRNA-1345 in participants who have been previously vaccinated with either Arexvy or Abrysvo at least 12 months prior to enrollment, are medically stable and aged ≥60 years.

Sponsor: ModernaTX, Inc.

Who Can Participate

Inclusion Criteria

Participants may have one or more chronic medical diagnoses, but should be medically stable as assessed by:
Absence of changes in medical therapy within 60 days of Visit 1 due to treatment failure or toxicity.
Absence of serious or significant medical events within 30 days of Visit 1.
Absence of known, current, and life-limiting diagnoses which, in the opinion of the Investigator, would make completion of the protocol unlikely.
Participant has received a single dose of Arexvy or Abrysvo at least 12 months prior to Visit 1. Participants must provide proof of RSV vaccination status (including brand and date received) prior to enrollment. Key

Exclusion Criteria

Participant has received or plans to receive any vaccine authorized or approved by a local health agency ≤14 days prior to study injection (Day 1) or plans to receive a vaccine authorized or approved by a local health agency within 14 days after the study injection. Nonstudy vaccinatio

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Savannah?

Yes, this clinical trial (NCT07117487) has an active research site in Savannah, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Respiratory Syncytial Virus Treatment Options in Savannah, GA

If you're searching for respiratory syncytial virus treatment options in Savannah, GA, this clinical trial (NCT07117487) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Savannah research site is actively enrolling participants for this clinical trial. You'll receive care from experienced respiratory syncytial virus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all respiratory syncytial virus clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Savannah, GA

See all rheumatoid arthritis clinical trials recruiting in Savannah — not just this study.

Browse Rheumatoid Arthritis Trials in Savannah

Ready to Join in Savannah?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Savannah, GA